Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App





Sysmex Showcases Latest Laboratory Innovations and Technologies

By LabMedica International staff writers
Posted on 04 Feb 2025

Sysmex (Kobe, Japan) is participating at Medlab Middle East 2025 as a platinum sponsor where the company is showcasing its latest laboratory innovations and technologies and also hosting workshops. More...

At the 2025 edition of Medlab Middle East, Sysmex is highlighting BloodScience Workcell, its novel laboratory automation concept which smartly combines hematology and hemostasis testing in one interdisciplinary solution – to support physicians in obtaining a more holistic picture of their patients and to improve the workflow in the laboratory. BloodScience Workcell consolidates the workflow automation of EDTA and citrate blood sample tubes by combining hematology automation lines, XR-9000 or XN-9100, with the new CN track for hemostasis. Also featured is the UN-Series of urinalysis solutions which can automate a lab’s urinalysis work area according to required workflow preferences. With modular components to mix and match, labs can tailor a complete solution that is scalable to their current and future needs, providing a perfect fit and a secure investment.

Sysmex is also showcasing its comprehensive line of IVD flow cytometry products, headlined by the advanced PS-10 sample preparation system and the XF-1600 flow cytometer, in addition to an extensive portfolio of monoclonal antibodies and consumables. Sysmex is demonstrating CyFlow WA, its innovative Work Area Manager (WAM) software, which is the key to a smartly connected modern clinical flow cytometry lab. It integrates seamlessly with existing Sysmex lab equipment, acting as a powerful middleware solution bridging hematology and clinical flow cytometry data analysis.

Among its other solutions, Sysmex is showcasing HISCL-800, the latest addition to its HISCL family of automated immunoassay systems. The unique features of HISCL-800 include fast reaction time with throughput of up to 100 tests per hour, delivering highly sensitive and specific clinical results with small footprint, making it an ideal partner for small and medium-sized laboratories. With a fast reaction time for every parameter, it takes 17 mins to get the first test result. The HISCL-800’s rapid analysis enables laboratories to meet their reporting objectives, especially for STAT samples. Visitors to the Sysmex booth can also view digital displays of its cancer diagnostic solutions for breast cancer and colorectal cancer.


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.